Multiple randomised controlled trials (2014–2019) confirm that shockwave significantly improves function in men with vascular ED.
A 2019 meta-analysis found shockwave is particularly effective for diabetic ED — a group for whom other treatments often fall short.
Research from Australia and Italy highlights high patient satisfaction, minimal side effects and no downtime.
Results have been shown to last up to 12 months post-treatment. A small number of top-up sessions at the 2-year mark may maintain results.
Shockwave has been shown to convert men who do not respond to oral medications into responders — making medication effective for men it previously didn't work for.









